Skip to main
DLB

Dolby Laboratories (DLB) Stock Forecast & Price Target

Dolby Laboratories (DLB) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

Dolby Laboratories Inc. demonstrated a 1.6% year-over-year increase in product and service revenues, with better-than-expected growth driven by favorable deal timings. The company's licensing segment, which accounts for nearly half of total revenues, is expected to benefit from the expansion of the Premium Large Format (PLF) concept and the rising adoption of its Atmos and Vision technologies, setting the stage for increased per-unit royalties as market volumes recover. Additionally, Dolby's strategic focus on SaaS-like models tied to patent licensing and its OptiView solution indicates a forward-thinking approach to generating sustainable, incremental revenue growth.

Bears say

Dolby Laboratories is projected to experience a 7.5% year-over-year decline in license revenue and a 5.7% drop in products and services for the December quarter, which is indicative of broader challenges in the PC and consumer electronics verticals. The company's gross margins have decreased to 89.8% from 90.8% due to lower margins in its Products/Services segment, and management anticipates a continued high-single-digit revenue decline for fiscal 2026, mirroring the issues faced in fiscal 2025. Additionally, revenue expectations for the first quarter suggest a 7% year-over-year decrease, exacerbated by a difficult comparison against last year’s performance and ongoing headwinds related to device volumes post-pandemic.

Dolby Laboratories (DLB) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Dolby Laboratories and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Dolby Laboratories (DLB) Forecast

Analysts have given Dolby Laboratories (DLB) a Buy based on their latest research and market trends.

According to 4 analysts, Dolby Laboratories (DLB) has a Buy consensus rating as of Apr 6, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $90.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $90.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Dolby Laboratories (DLB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.